KIR3DL1 and acute lymphoblastic leukemia: However, in the study by Cooley et al., 2010 [1], which included 1409 patients with AML or acute lymphoblastic leukemia (ALL) undergoing unmanipulated allogeneic HSCT, donor KIR B haplotype status was not associated with differences in NRM, acute GvHD (aGvHD), or cGvHD.